Gamida Cell confirms Novartis investment

August 19, 2014 9:37 AM

9 0

Novartis will invest $35 million in Gamida Cell for 15% equity and an option to acquire it fully.

Gamida Cell, which develops stem cell expansion technologies and therapeutic products, announced today that it has signed an investment and option agreement with Novartis Pharma AG. According to the agreement, Novartis will invest $35 million in Gamida Cell and in return will receive 15% equity and ...

Read more

To category page

Loading...